BioHealth News
BioTalk – Driving Cancer Research Innovation: A Conversation with Michael Weingarten, Director, SBIR Development Center at the National Cancer Institute (NCI)
What are the latest advancements in cancer research and innovation? Join us in this episode of BioTalk with Rich Bendis as we explore the…
Read More
BioHealth Innovation, Inc. Welcomes Dr. Eric S. Edwards of Phlow Corporation to the Board of Directors and Appoints Donna J. Edmonds of BRAINBox Solutions, Inc. as Vice Chair
ROCKVILLE, MARYLAND, November 13, 2023 – BioHealth Innovation, Inc. (BHI), a leading organization dedicated to supporting and advancing the BioHealth industry, is pleased to…
Read More
The NHLBI is accepting applications for the I-Corps at NIH™ Program
The NHLBI is accepting applications for the I-Corps at NIH™ Program, which provides funding, mentoring, and networking opportunities to current Phase I SBIR/STTR awardees and Fast-Track awardees in the first phase of…
Read More
VLP Therapeutics group announces 3rd closing of funding to develop cancer, infectious disease vaccines; establish investigational vaccine manufacturing facility
US-based biotech company VLP Therapeutics, Inc. (VLPT) and its Tokyo-based group company VLP Therapeutics Japan, Inc. (VLPT Japan) together announced on November 8 the…
Read More
Emergent BioSolutions Submits Supplemental Biologics License Application Seeking U.S. FDA Approval of ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) for Immunization Against Mpox
GAITHERSBURG, Md., November 7, 2023 – Emergent (NYSE: EBS) has recently submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug…
Read More
Irazú Oncology and University of Maryland, Baltimore Mark Anniversary of Exclusive License for Development of Colorectal Cancer Vaccine
BALTIMORE, MD, November 7, 2023 –Irazú Oncology, LLC, a biotechnology research company working to develop the next generation of cancer vaccines, and University of…
Read More
Endpoints News Exclusive: With backing of Ravens owner, Blackbird launches with $100M to boost Baltimore’s biotech scene
A life sciences accelerator called Blackbird Laboratories has $100 million to spend to turn Baltimore into a biotech hub.A life sciences accelerator called Blackbird…
Read More
Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer
OXFORD, United Kingdom, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company developing…
Read More
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
Up to 60,000 patients in the United States may have PPF, with only one approved therapy available SILVER SPRING, Md. & RESEARCH TRIANGLE PARK,…
Read More
BioBuzz: Addimmune Prepares to go Public, Initiate Phase Ib HIV Trial
By Alex Keown | October 31, 2023 - Addimmune, currently American Gene Technologies HIV-focused research, is expected to become a publicly traded company in early 2024 following…
Read More
Johnson & Johnson Innovation Names Awardees in the Advancing Oncology InnoVAtion QuickFire Challenge
October 25th, 2023 – Johnson & Johnson Innovation, in collaboration with Carilion Clinic Innovation, Verge Alliance (with support from City of Roanoke), and Virginia Tech…
Read More
Indo US Bridging Rare Summit Heralds a New Era of Cooperation for Rare Diseases Orphan Drugs Development
The FDA’s Commissioner, Dr. Robert M. Califf, recently visited India and shared his opinion on India’s Unique Opportunity and Important Responsibility as the Pharmacy…
Read More
Unlocking the Future of Stem Cell Research with MSCRF: A Conversation with Ruchika Nijhara, PhD, Executive Director of Maryland Stem Cell Research Fund (MSCRF)
Are you curious about the world of transformative regenerative medicine and stem cell research? Are you eager to understand how Maryland champions researchers and…
Read More
QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI System
Partnership combines QIAGEN’s QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element’s AVITI System users in genomic analysis Collaboration to accelerate discovery,…
Read More
ATCC and USP Launch First Set of Products to Advance Quality and Reduce Risk in the Development of Biological Therapeutics and Vaccines
Six new products that can be used to detect residual host cell genomic DNA (gDNA) MANASSAS, Va. and ROCKVILLE, Md., Oct. 30, 2023 /PRNewswire/ -- Today, ATCC and U.S. Pharmacopeia…
Read More